Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
about
Fluids and diuretics for acute ureteric colicFluids and diuretics for acute ureteric colicNADPH oxidase as a therapeutic target for oxalate induced injury in kidneysPhysico-chemical alterations of urine in experimental hyperoxaluria: a biochemical approach with fucoidan.1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat modelCombination of vitamin E and vitamin C alleviates renal function in hyperoxaluric rats via antioxidant activity.Interaction between submicron COD crystals and renal epithelial cells.Unified theory on the pathogenesis of Randall's plaques and plugsIdiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as pThe alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol.Metabolic syndrome and nephrolithiasis.The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury.Alkalizer administration improves renal function in hyperuricemia associated with obesity.Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells.Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.Crystal nephropathies: mechanisms of crystal-induced kidney injury.Mechanisms of Stone Formation.Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.Role of Vitamin C and E supplementation in reduction of serum level of renal injury marker following shock wave lithotripsy: Prospective single centre experience.Oxidative stress and antioxidant status in patients with complicated urolithiasis.Antiurolithiatic Activity of Whole-Plant Hydroalcoholic Extract of Pergularia daemia in Rats.Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney.How do stones form? Is unification of theories on stone formation possible?Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.Effect of sulphated polysaccharides on erythrocyte changes due to oxidative and nitrosative stress in experimental hyperoxaluria.Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis.Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.Changes of Klotho protein and Klotho mRNA expression in a hydroxy-L-proline induced hyperoxaluric rat model.The impact of klotho gene polymorphisms on urinary tract stone disease.Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis.Patients with nephrolithiasis had lower fetuin-A protein level in urine and renal tissue.Circadian Periodicity of Circulating Plasma Lipid Peroxides, Uric Acid and Ascorbic Acid in Renal Stone Formers.Melatonin reduces uranium-induced nephrotoxicity in rats
P2860
Q24203671-90AD6E35-7D13-4D6A-89E6-A09D3FCA06C6Q24246584-8BE69979-D7C2-484D-B97B-6EAC7EB103E1Q27014373-ED0C8CAB-7D84-4E8C-9996-95D0CDFD3EFEQ33276301-23502F3A-D66D-4AC2-82E3-1A02A65EAD3DQ33602559-FA4C76DF-AFD9-4946-932F-926D5C083F0AQ33737348-E473C52A-6363-45D1-AA02-42039F34BD87Q34413559-266333B4-04EE-423E-B0EE-67AD04B98D02Q35216521-A78501FD-C219-4E26-8C34-B5845C50ED45Q35959059-B1161D4D-F65A-47DC-9721-F7C3378615C4Q36147617-92A933E5-4357-4792-B5CD-7CE979B19563Q36451152-1670C791-D548-46E7-8732-4196472BBA40Q36737559-66BED713-FA55-4D99-863A-30C5C39997DEQ37092300-5BE6A20B-42AF-4BBE-A2BA-1F903621B984Q37430733-A62CA503-E095-4203-B931-85E6C34E2548Q37972817-6AEE1A8D-A3A0-485A-A9F4-C7FB991AFF23Q38874052-3089F40D-78C7-4E95-AF78-86533AA9B02DQ39144172-3B5E32EB-2211-4A05-A7A7-EADD215B3FE1Q40198027-0FA82BF1-6E13-494D-9D90-21569AAB8CD0Q41919477-887B079F-F782-4B95-97A7-EBC0C91ED61FQ42070826-CD46D065-3D27-4056-A040-81185C8FFE28Q42353393-551AD09B-0A6E-4056-8DDB-F22D9D34BB6DQ42733828-5645E2A9-CD14-471B-815B-0B10E5B7BEA8Q42744183-04A6C992-5E8B-4969-998B-3BD2201A1D6CQ43240432-49069CD6-6A51-497C-88AD-AE47C9D05F41Q46414748-F9C87F5E-4669-448D-878B-BD2A7D4102DBQ46552906-3C008D0A-6F45-4FFA-8D9A-CBDA21E31073Q46674728-2BCD9EB2-6BFB-43C8-B8E7-0E73CB24F98AQ46778146-D6D9D170-5106-40F8-88E7-7CF039063E48Q46786685-3BD79D3F-77E2-4300-9518-B229DB993298Q46866912-DC3D9FE3-FCB4-47F6-9B6B-2A8988964A04Q46918513-E70F92FC-6821-4AB8-B284-682B5BA98462Q47131429-3BA7346B-C5FE-4986-B8EF-E330EE21C749Q48100012-E4AFBFFF-F6C2-4B4F-87E2-808F84A88E5AQ50957813-665B1254-E268-43B3-85A9-4B376C77C954Q54237797-C4F263E8-8B12-43EF-8AEA-A090853CA346Q55017086-344DA30E-3F0D-4E74-8AB5-CD132B0A6224Q57266523-9F3BFAEA-B07C-46AF-B678-E10F4C75D40D
P2860
Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Renal tubular cell damage and ...... f potassium citrate treatment.
@en
Renal tubular cell damage and ...... f potassium citrate treatment.
@nl
type
label
Renal tubular cell damage and ...... f potassium citrate treatment.
@en
Renal tubular cell damage and ...... f potassium citrate treatment.
@nl
prefLabel
Renal tubular cell damage and ...... f potassium citrate treatment.
@en
Renal tubular cell damage and ...... f potassium citrate treatment.
@nl
P2093
P1433
P1476
Renal tubular cell damage and ...... f potassium citrate treatment.
@en
P2093
Chatchai Yachantha
Kriang Tungsanga
Piyaratana Tosukhowong
Pote Sriboonlue
Prasit Futrakul
P356
10.1007/S00240-004-0444-4
P577
2004-11-25T00:00:00Z